News

Dapagliflozin cuts cardiovascular events in patients with heart failure, T2D

31 Dec: Dapagliflozin cuts cardiovascular events in patients with heart failure, T2D

For patients with heart failure and type 2 diabetes (T2D), dapagliflozin does not reduce urinary albumin-to-creatinine ratio (UACR) but does reduce some cardiovascular events, according to a study published online Nov. 27 in eClinicalMedicine. Fumiki Yoshihara, from the National Cerebral and Cardiovascular Center in Osaka, Japan, and colleagues conducted a multicenter, randomized trial that enrolled

29 Dec: tDCS Promising for Improved Cognition in Alzheimer’s

TOPLINE: Transcranial direct current stimulation (tDCS) delivered twice daily over 6 weeks can improve cognitive function in patients with Alzheimer’s disease (AD), highlighting the potential of tDCS as a therapeutic intervention, new research shows.  METHODOLOGY: The study enrolled 124 patients with mild to moderate AD, with 63 randomly allocated to receive active tDCS and 61

21 Dec: ECG Deep-Learning Algorithm Predicts Mortality Post Surgery

TOPLINE: An artificial intelligence (AI) deep-learning algorithm interpreting preoperative ECGs can identify risk for postoperative death in those undergoing cardiac surgery, noncardiac surgery, and interventional procedures, a large new study showed. The algorithm was more effective in identifying high-risk patients who went on to experience postoperative mortality than a widely used risk tool…

21 Dec: Passing of Dr Jean-Philippe Collet

Jean-Philippe Collet, MD, head of medical cardiology at Pitié-Salpêtrière Hospital, Paris, France, passed away suddenly on Friday, December 15, at the age of 59 years. The cardiology community, still in shock, mourns the loss. Dr Jean-Philippe Collet “Cardiology loses a genius, and patients lose a beloved doctor…He was a mentor to us all…